← Back to Patent Explorer
US5286866A Expired / Lapsed US ⏱️ 0.0 years remaining

Piperidinyl compounds

Assignee: Aventis Pharmaceuticals Inc
•
Filing: 1992-02-14
•
Granted: 1994-02-15
•
Expires: 2012-02-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention pertains to a new class of compounds which can be characterized as 1,4-disubstituted piperidinyl compounds useful as antiarrhythmics, analgesics, and serotonin 5HT 2 antagonists.

Inventors

  • 👤 Albert A. Carr
  • 👤 John E. Koerner
  • 👤 Richard C. Dage
  • 👤 Tung Li

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 11:17
CPC Classifications
C; C07; C07D; C07D211/00; C07D211/04; C07D211/06; C07D211/08; C07D211/18; C07D211/26; C07D211/28; C07D211/20; C07D211/22; C07D211/30; C07D211/32

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 69 words
A 1,4-disubstituted piperidinyl compound having the formula: ##STR7## wherein; Y is CO(CH 2 ) n CH 3 in which n is an integer from 0-3; X is selected from the group consisting of C═O and CHOH; R is selected from the group consisting of hydrogen, halogen, C 1-4 alkyl, C 1-4 alkoxy, 3,4-methylenedioxy and 3,4-ethylenedioxy; m is an integer from 1-5 and the pharmaceutically acceptable acid addition salts thereof.
Claim 2
Dependent Claim 69 words
A 1,4-disubstituted piperidinyl compound having the formula: ##STR7## wherein; Y is CO(CH 2 ) n CH 3 in which n is an integer from 0-3; X is selected from the group consisting of C═O and CHOH; R is selected from the group consisting of hydrogen, halogen, C 1-4 alkyl, C 1-4 alkoxy, 3,4-methylenedioxy and 3,4-ethylenedioxy; m is an integer from 1-5 and the pharmaceutically acceptable acid addition salts thereof.
Claim 3
Dependent Claim 14 words
A compound of claim 1 which is N-[4-[[1-(2-phenylethyl)-4-piperidinyl]carbonyl]phenyl]acetamide and the pharmaceutically acceptable salts thereof.
Claim 4
Dependent Claim 14 words
A compound of claim 1 which is N-[4-[hydroxy-[1-(2-phenylethyl)-4-piperidinyl]methyl]phenyl]acetamide and the pharmaceutically acceptable salts thereof.

References Cited (Backward Citations)

US3037986A Cited
US4783471A Cited
US4876262A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-02-14 1997-08-16 1998-02-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-02-14 2001-08-16 2002-02-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-02-14 2005-08-16 2006-02-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag